DIA-TOPRA Workshop on Falsified Medicines

This conference will take stock of where we stand in the EU on falsified medicines and paint the landscape of the global issue. The speakers will present the approaches of the Member States on the implementation of the new legislation, and the impact and achievements of the concerned stakeholders such as industry, patients, pharmacies and distributors who have worked independently and together to find solutions.

戻る Agenda

Session 2 – Panel discussion with various stakeholders

Session Chair(s)

Gerald W. Heddell

Director, Inspection Enforcement & Standards Division

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Speaker(s)

Innovator Industry Perspective

Francois Bouvy

EFPIA, Belgium

Martin Fitzgerald

European Healthcare Distribution Association (GIRP), Belgium

Deputy Director General

European Generic and Biosimilar Medicine Industry View

Maarten Van Baelen, MBA, MPHARM

Medicines for Europe, Belgium

Market Access Director

Hospital Pharmacists' Perspective

Robert Moss

European Hospital Pharmacists' Association, Belgium

Board Member; Director

Patients' Perspective

Stephen McMahon

Irish Patients Association, Ireland

Chairman